We are live on
!
Find out more
FDCC
Foster Dykema Cabot & Co Portfolio holdings
AUM
$827M
1-Year Est. Return
18.87%
This Fund
S&P 500
This Quarter
Est. Return
-2.47%
1 Year Est. Return
+18.87%
3 Year Est. Return
+34.03%
5 Year Est. Return
+67.09%
10 Year Est. Return
+162.67%
AUM
$796M
AUM Growth
-$14.5M
(-1.8%)
Cap. Flow
+$7.33M
Cap. Flow
% of AUM
0.92%
Top 10 Holdings %
Top 10 Hldgs %
68.03%
Holding
114
New
8
Increased
17
Reduced
28
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$12.8M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$12.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$12.6M |
| 4 |
Northrop Grumman
NOC
|
+$12M |
| 5 |
Waste Management
WM
|
+$11.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$32.7M |
| 2 |
Sherwin-Williams
SHW
|
+$15.8M |
| 3 |
Lowe's Companies
LOW
|
+$6.11M |
| 4 |
American Express
AXP
|
+$5.81M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$4.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.61% |
| 2 | Financials | 7.22% |
| 3 | Healthcare | 6.72% |
| 4 | Industrials | 4.56% |
| 5 | Consumer Discretionary | 4.4% |
Similar funds
FBA
MAM
IWP
DBT
CCA
FMAEN1
WWM
RWA
Foster Dykema Cabot & Co's Q3 2022 Portfolio in Review
As of Q3 2022, Foster Dykema Cabot & Co held 114 positions worth $796M, down 1.8% from $811M the previous quarter. Its ten largest holdings account for 68% of the portfolio.
Foster Dykema Cabot & Co's Q3 2022 filing shows 8 new, 17 increased, 28 reduced and 9 closed positions. Its largest new stake was State Street Health Care Select Sector SPDR ETF: 98,440 shares worth $11.9M. The largest sale was iShares Core MSCI EAFE ETF, an estimated $32.7M.
By sector, the portfolio is most concentrated in Technology at 8.6% of assets, down from 8.7% a quarter earlier, followed by Financials and Healthcare.
- Foster Dykema Cabot & Co's largest Q3 2022 buy was State Street Health Care Select Sector SPDR ETF: 98,440 shares worth $11.9M.
- Foster Dykema Cabot & Co added most to Eli Lilly in Q3 2022, an estimated $12.8M increase.
- Foster Dykema Cabot & Co's biggest Q3 2022 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $32.7M.
- Foster Dykema Cabot & Co fully exited Heliogen, Inc. in Q3 2022, selling an estimated $1.58M.
- Foster Dykema Cabot & Co's ten largest holdings make up 68% of its $796M portfolio in Q3 2022.
- Foster Dykema Cabot & Co opened 8 new positions and closed 9 in Q3 2022.
- Foster Dykema Cabot & Co's portfolio value fell 1.8% quarter-over-quarter to $796M.
Based on Foster Dykema Cabot & Co's 13F filing for Q3 2022, filed 20 Oct 2022.